Share of Cost, Genomic testing can help identify patients at heightened risk for esophageal cancer

Thursday, Aug. 27th 2015 6:00 AM

Philadelphia, PA, June 8, 2015 – Barrett’s esophagus (BE) develops in a subset of patients with gastroesophageal reflux disease (GERD) and can increase the risk of developing cancer of the esophagus. Although periodic surveillance for cancer is recommended for BE patients, these examinations may fail to identify pre-cancerous dysplasia and early cancers. A report in the Journal of Molecular Diagnostics describes a test using next-generation sequencing (NGS) to detect genomic mutations in precancerous esophageal tissue, which may improve cancer surveillance and early detection in patients with BE.

Posted on Thursday, Aug. 27th 2015 6:00 AM | by Share of Cost | in Share of Cost | Comments Off on Share of Cost, Genomic testing can help identify patients at heightened risk for esophageal cancer